Market News
Friday, March 25, 2016
BRIEF-Oxigene says receives European orphan drug designation for CA4P
* European commission has granted orphan drug designation to CA4P for treatment of gastro-entero-pancreatic neuroendocrine tumors
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment